AbstractDyslipidemia, inflammation and gender are major risk factors in cardiovascular disease. Here we show that hepatic expression of Peroxisome proliferator-activated receptor α (PPARα), a nuclear receptor that regulates lipid metabolism and inflammation, is regulated in a gender-specific manner during lipopolysaccharide (LPS)-induced systemic inflammation. Immediately following LPS-induced systemic inflammation, hepatic PPARα mRNA level decreased dramatically in mice. It was restored to baseline within 24 h in females but remained below baseline for >72 h in male mice. In gonadectomized mice of both sexes, PPARα mRNA level was restored to baseline within 48 h after the initial decrease
SummaryPeroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription fact...
Abnormal lipid metabolism has been associated with a wide range of chronic and infectious diseases i...
International audienceObjective We evaluated the influence of sex on the pathophysiology of non-alco...
International audienceOBJECTIVE: Peroxisome proliferator-activated receptor-α (PPARα) is a ligand-ac...
International audienceOBJECTIVE: Peroxisome proliferator-activated receptor-α (PPARα) is a ligand-ac...
The peroxisome proliferator activated receptor alpha (PPARα) is a ligand activated tran- scription f...
AbstractCells are constantly exposed to a large variety of lipids. Traditionally, these molecules we...
International audienceOBJECTIVE: Peroxisome proliferator-activated receptor-α (PPARα) is a ligand-ac...
Chronic disorders, such as obesity, diabetes, inflammation, non-alcoholic fatty liver disease and at...
Chronic disorders, such as obesity, diabetes, inflammation, non-alcoholic fatty liver disease and at...
We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD...
We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD...
SummaryPeroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription fact...
The peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription factor ...
The peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription factor ...
SummaryPeroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription fact...
Abnormal lipid metabolism has been associated with a wide range of chronic and infectious diseases i...
International audienceObjective We evaluated the influence of sex on the pathophysiology of non-alco...
International audienceOBJECTIVE: Peroxisome proliferator-activated receptor-α (PPARα) is a ligand-ac...
International audienceOBJECTIVE: Peroxisome proliferator-activated receptor-α (PPARα) is a ligand-ac...
The peroxisome proliferator activated receptor alpha (PPARα) is a ligand activated tran- scription f...
AbstractCells are constantly exposed to a large variety of lipids. Traditionally, these molecules we...
International audienceOBJECTIVE: Peroxisome proliferator-activated receptor-α (PPARα) is a ligand-ac...
Chronic disorders, such as obesity, diabetes, inflammation, non-alcoholic fatty liver disease and at...
Chronic disorders, such as obesity, diabetes, inflammation, non-alcoholic fatty liver disease and at...
We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD...
We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD...
SummaryPeroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription fact...
The peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription factor ...
The peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription factor ...
SummaryPeroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription fact...
Abnormal lipid metabolism has been associated with a wide range of chronic and infectious diseases i...
International audienceObjective We evaluated the influence of sex on the pathophysiology of non-alco...